An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Dizziness and Neck Pain: A Perspective on Cervicogenic Dizziness

Dizziness, Weightless Tongue, Baby Feet: Challenges Astronauts Face Upon Return to Earth

The Role of Socioeconomic Factors on Cochlear Implantation

Recent Posts

Dizziness and Neck Pain: A Perspective on Cervicogenic Dizziness

Cervicogenic dizziness is a somewhat controversial topic, as this condition is often considered a diagnosis of exclusion without a specific objective standardized test across health-care…

Read More
he Old State Capitol Building at Tallahassee Florida FL.

Audiologists Advocate for Fair Use of “Doctor” Title in Florida

This week, the American Academy of Audiology, in collaboration with the Florida Academy of Audiology (FLAA), voiced concerns about House Bill (HB) 1341—legislation that would…

Read More
Close-up shot of Arkansas flag swinging at Arkansas

Arkansas Enacts Law Expanding Audiologists’ Scope of Practice

Arkansas Senate Bill 118 has been signed into law, updating the state’s audiology scope of practice statute. The law allows audiologists who are licensed to…

Read More